BNP Paribas Asset Management Portfolio holdings
AUM
$41B
1-Year Return
19.31%
This Quarter Return
+14.3%
1 Year Return
+19.31%
3 Year Return
+95.01%
5 Year Return
+143.6%
10 Year Return
+355.3%
AUM
$41B
AUM Growth
+$3.68B
(+9.9%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-1.49%
Top 10 Holdings %
Top 10 Hldgs %
28.62%
Holding
2,107
New
1,243
Increased
434
Reduced
374
Closed
26
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$192M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$151M |
| 3 |
Bank of America
BAC
|
+$114M |
| 4 |
CME Group
CME
|
+$112M |
| 5 |
Accenture
ACN
|
+$99.8M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$195M |
| 2 |
Amazon
AMZN
|
+$195M |
| 3 |
Advanced Micro Devices
AMD
|
+$127M |
| 4 |
Eli Lilly
LLY
|
+$115M |
| 5 |
Automatic Data Processing
ADP
|
+$102M |
Sector Composition
| 1 | Technology | 36.76% |
| 2 | Healthcare | 12.99% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.32% |
| 5 | Communication Services | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CG Oncology
CGON
$2.57B
| $10K | ﹤0.01% |
+381
| New | +$10K |
|
1677
Cipher Mining
CIFR
$3.63B
| $10K | ﹤0.01% |
+2,125
| New | +$10K |
|
1678
Calumet Specialty Products
CLMT
$1.5B
| $10K | ﹤0.01% |
+608
| New | +$10K |
|
1679
Clover Health Investments
CLOV
$1.48B
| $10K | ﹤0.01% |
+3,614
| New | +$10K |
|
1680
Compass Minerals
CMP
$794M
| $10K | ﹤0.01% |
+478
| New | +$10K |
|
1681
Collegium Pharmaceutical
COLL
$1.19B
| $10K | ﹤0.01% |
+340
| New | +$10K |
|
1682
Diebold Nixdorf
DBD
$2.23B
| $10K | ﹤0.01% |
+173
| New | +$10K |
|
1683
Dillards
DDS
$9.03B
| $10K | ﹤0.01% |
+24
| New | +$10K |
|
1684
Dynavax Technologies
DVAX
$1.14B
| $10K | ﹤0.01% |
+969
| New | +$10K |
|
1685
Heritage Commerce
HTBK
$633M
| $10K | ﹤0.01% |
+959
| New | +$10K |
|
1686
MarineMax
HZO
$566M
| $10K | ﹤0.01% |
+394
| New | +$10K |
|
1687
Lakeland Financial Corp
LKFN
$1.74B
| $10K | ﹤0.01% |
+155
| New | +$10K |
|
1688
LeMaitre Vascular
LMAT
$2.2B
| $10K | ﹤0.01% |
+119
| New | +$10K |
|
1689
Marcus & Millichap
MMI
$1.28B
| $10K | ﹤0.01% |
+314
| New | +$10K |
|
1690
Middlesex Water
MSEX
$957M
| $10K | ﹤0.01% |
+192
| New | +$10K |
|
1691
MaxLinear
MXL
$1.38B
| $10K | ﹤0.01% |
+737
| New | +$10K |
|
1692
N-able
NABL
$1.56B
| $10K | ﹤0.01% |
+1,295
| New | +$10K |
|
1693
NeoGenomics
NEO
$1.02B
| $10K | ﹤0.01% |
+1,392
| New | +$10K |
|
1694
Phibro Animal Health
PAHC
$1.6B
| $10K | ﹤0.01% |
+382
| New | +$10K |
|
1695
Pacira BioSciences
PCRX
$1.2B
| $10K | ﹤0.01% |
+426
| New | +$10K |
|
1696
PDF Solutions
PDFS
$785M
| $10K | ﹤0.01% |
+471
| New | +$10K |
|
1697
Dave & Buster's
PLAY
$805M
| $10K | ﹤0.01% |
+322
| New | +$10K |
|
1698
Root
ROOT
$1.52B
| $10K | ﹤0.01% |
+79
| New | +$10K |
|
1699
Rapid7
RPD
$1.33B
| $10K | ﹤0.01% |
+427
| New | +$10K |
|
1700
Rush Street Interactive
RSI
$2B
| $10K | ﹤0.01% |
+675
| New | +$10K |
|